Tower Research Capital (TRC)’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q1
Sell
-162
Closed -$1K 5544
2013
Q4
$1K Sell
162
-294
-64% -$1.82K ﹤0.01% 4377
2013
Q3
$3K Sell
456
-744
-62% -$4.9K ﹤0.01% 4049
2013
Q2
$8K Buy
+1,200
New +$8K ﹤0.01% 2645